Serological assays for delayed SARS-CoV-2 case identification - Author's reply.
作者信息
Pallett Scott J C, Rayment Michael, Patel Aatish, Charani Esmita, Denny Sarah J, Fitzgerald-Smith Sophia A M, Mughal Nabeela, Jones Rachael, Davies Gary W, Moore Luke S P
机构信息
Centre of Defence Pathology, Royal Centre for Defence Medicine, Queen Elizabeth Hospital Birmingham, Birmingham B15 2WB, UK; Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.
Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.
出版信息
Lancet Respir Med. 2020 Oct;8(10):e74. doi: 10.1016/S2213-2600(20)30406-9. Epub 2020 Sep 14.
Abstract
摘要
相似文献
1
Serological assays for delayed SARS-CoV-2 case identification - Author's reply.
Lancet Respir Med. 2020 Oct;8(10):e74. doi: 10.1016/S2213-2600(20)30406-9. Epub 2020 Sep 14.
2
Serological assays for delayed SARS-CoV-2 case identification.
Lancet Respir Med. 2020 Oct;8(10):e73. doi: 10.1016/S2213-2600(20)30409-4. Epub 2020 Sep 14.
3
In Reply to 'Is SARS-CoV-2 Serology Relevant for Hemodialysis Patients With COVID-19?'.
Am J Kidney Dis. 2020 Oct;76(4):598-599. doi: 10.1053/j.ajkd.2020.06.005. Epub 2020 Jun 27.
4
Reply.
Am J Obstet Gynecol. 2020 Nov;223(5):776. doi: 10.1016/j.ajog.2020.08.023. Epub 2020 Aug 13.
5
Evaluation of Three Commercial Automated Assays for the Detection of Anti-SARS-CoV-2 Antibodies.
Clin Chem. 2020 Oct 1;66(10):1351-1353. doi: 10.1093/clinchem/hvaa193.
6
A Commentary on "A comparative overview of COVID-19, MERS and SARS: Review article" (International Journal of Surgery 2020; 81:1-8).
Int J Surg. 2020 Nov;83:28-29. doi: 10.1016/j.ijsu.2020.08.049. Epub 2020 Sep 11.
7
Reply to "Indications and timing for tracheostomy in patients with SARS CoV2-related" by Ferri et al.
Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2405-2406. doi: 10.1007/s00405-020-06134-0. Epub 2020 Jun 17.
8
[Analysis of coronavirus disease-19 (COVID-19) based on SARS autopsy].
Zhonghua Bing Li Xue Za Zhi. 2020 Apr 8;49(4):291-293. doi: 10.3760/cma.j.cn112151-20200211-00114.
9
Reply.
Am J Obstet Gynecol. 2020 Nov;223(5):786-788. doi: 10.1016/j.ajog.2020.06.017. Epub 2020 Jun 9.
10
Comparison of clinical characteristics of coronavirus disease (COVID-19) and severe acute respiratory syndrome (SARS) as experienced in Taiwan.
Travel Med Infect Dis. 2020 Jul-Aug;36:101625. doi: 10.1016/j.tmaid.2020.101625. Epub 2020 Mar 14.
本文引用的文献
1
Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence survey.
Thorax. 2020 Dec;75(12):1082-1088. doi: 10.1136/thoraxjnl-2020-215732. Epub 2020 Aug 12.
2
Characterising differential antibody response is integral to future SARS-CoV-2 serostudies.
J Infect. 2020 Dec;81(6):e28-e30. doi: 10.1016/j.jinf.2020.07.029. Epub 2020 Jul 31.
3
Point-of-care serological assays for delayed SARS-CoV-2 case identification among health-care workers in the UK: a prospective multicentre cohort study.
Lancet Respir Med. 2020 Sep;8(9):885-894. doi: 10.1016/S2213-2600(20)30315-5. Epub 2020 Jul 24.
4
SARS-CoV-2: virus dynamics and host response.
Lancet Infect Dis. 2020 May;20(5):515-516. doi: 10.1016/S1473-3099(20)30235-8. Epub 2020 Mar 23.
5
[Analysis of false-positive associated with antibody tests for SARS-CoV in SLE patients].
Shi Yan Sheng Wu Xue Bao. 2003 Aug;36(4):314-7.
Zotero 插件